Impact of medication therapy discontinuation on mortality after myocardial infarction.

作者: P. Michael Ho , John A. Spertus , Frederick A. Masoudi , Kimberly J. Reid , Eric D. Peterson

DOI: 10.1001/ARCHINTE.166.17.1842

关键词:

摘要: Background: Nonadherence to medications is common, but the determinants and consequences are poorly defined. The objectives of this study were identify patient myocardial infarction (MI) treatment factors associated with medication therapy discontinuation assess impact 1 month after MI on 12-month mortality. Methods: This was a multicenter prospective cohort patients enrolled in Prospective Registry Evaluating Myocardial Infarction: Event Recovery study.Theoutcomeswereuseofaspirin,-blockers,and statins at hospitalization among discharged all 3 as well 12month Results: Of 1521 medications,184discontinueduseofall3medications,56discontinued use 2 medications, 272 discontinued medication, 1009 continued taking month. In multivariable analyses, not graduating from high school (odds ratio [OR], 1.76; 95%confidenceinterval[CI],1.20-2.60)weremorelikely discontinue medications. effect increasing age greater for females (OR, 1.77; 95% CI, 1.34-2.34) than males 1.23; 1.02-1.47). Patients who had lower 1-yearsurvival(88.5%vs97.7%;log-rankP.001)comparedwithpatientswhocontinuedtotake1ormoremedication(s). survival analysis, independently higher mortality (hazards ratio, 3.81; 1.887.72). Results consistent when evaluating aspirin, -blockers, separately.

参考文章(28)
John D. Piette, Interactive voice response systems in the diagnosis and management of chronic disease. The American Journal of Managed Care. ,vol. 6, pp. 817- 827 ,(2000)
Jane Irvine, Brian Baker, Janice Smith, Stacey Jandciu, Miney Paquette, John Cairns, Stuart Connolly, Robin Roberts, Michael Gent, Paul Dorian, Poor Adherence to Placebo or Amiodarone Therapy Predicts Mortality: Results From the CAMIAT Study Psychosomatic Medicine. ,vol. 61, pp. 566- 575 ,(1999) , 10.1097/00006842-199907000-00023
Eugene Z. Oddone, Hayden B. Bosworth, Morris Weinberger, Patient Treatment Adherence : Concepts, Interventions, and Measurement Lawrence Erlbaum Associates. pp. 329- 372 ,(2005) , 10.4324/9781410615626
William J. Rogers, John G. Canto, Costas T. Lambrew, Alan J. Tiefenbrunn, Becky Kinkaid, David A. Shoultz, Paul D. Frederick, Nathan Every, Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999: The National Registry of Myocardial Infarction 1, 2 and 3 Journal of the American College of Cardiology. ,vol. 36, pp. 2056- 2063 ,(2000) , 10.1016/S0735-1097(00)00996-7
Sabina De Geest, Eduardo Sabaté, Adherence to Long-Term Therapies: Evidence for Action: European Journal of Cardiovascular Nursing. ,vol. 2, pp. 323- 323 ,(2003) , 10.1016/S1474-5151(03)00091-4
G O'Donovan, A Owen, E M Kearney, D W Jones, A M Nevill, K Woolf-May, S R Bird, Cardiovascular disease risk factors in habitual exercisers, lean sedentary men and abdominally obese sedentary men International Journal of Obesity. ,vol. 29, pp. 1063- 1069 ,(2005) , 10.1038/SJ.IJO.0803004
Kenneth A. LaBresh, A. Gray Ellrodt, Richard Gliklich, James Liljestrand, Randolph Peto, Get With the Guidelines for Cardiovascular Secondary Prevention Archives of Internal Medicine. ,vol. 164, pp. 203- 209 ,(2004) , 10.1001/ARCHINTE.164.2.203
E. C. Yiannakopoulou, J. S. Papadopulos, D. V. Cokkinos, T. D. Mountokalakis, Adherence to antihypertensive treatment: a critical factor for blood pressure control. European Journal of Preventive Cardiology. ,vol. 12, pp. 243- 249 ,(2005) , 10.1097/01.HJR.0000160601.41762.44
Ralph I Horwitz, Catherine M Viscoli, RM Donaldson, CJ Murray, DF Ransohoff, Lisa Berkman, SM Horwitz, Jody Sindelar, None, Treatment adherence and risk of death after a myocardial infarction. The Lancet. ,vol. 336, pp. 542- 545 ,(1990) , 10.1016/0140-6736(90)92095-Y